ImmunityBio delivered strong 3Q25 results, with Anktiva driving 434% YoY product revenue growth and a narrowed operating loss ...
Ooops... Something went wrong while loading this page.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback